ArticleDrugs in R&D2025

Evaluation of Anti-SARS-CoV-2 IgG Responses in a Clinical Study of a Biosimilar Candidate to Denosumab Using Singlicate Analysis.

Sandra Ribes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.